CLASSIFICATION OF AGA IN MALES: THE HAMILTON-NORWOOD SYSTEM DISCLOSURE OF CONFLICTS OF INTEREST
|
|
- Clinton Dickerson
- 6 years ago
- Views:
Transcription
1 DISCLOSURE OF CONFLICTS OF INTEREST Investigator: Allergan, Intendis, Procter & Gamble, Abbott, Samumed, Cassiopea, Bayer, Galderma Amy McMichael, MD Professor and Chair Department of Dermatology Wake Forest Baptist Health Winston-Salem, NC Fall Clinical October 2016 Consultant: Procter & Gamble, Johnson & Johnson, Stiefel, Allergan, Galderma, Guthey Renker, Bayer, Healthwise, Merz, Incyte, Samumed, Aclaris, Anacor, Pfizer (A) Grade I (B) Grade II (C) Grade III Ludwig E. British J Dermatol.1977;97:247. Reprinted with permission from British J Dermatol. CLASSIFICATION OF AGA IN MALES: THE HAMILTON-NORWOOD SYSTEM Plasma rich platelets Bimatoprost 29 yo man treated with PRP Topical Wnt pathway activation Oral PGD2 receptor antagonist Hamilton JB. Ann NY Acad Dermatol. 1951;53: Norwood OT. South Med J.1975;68: Reprinted with permission from South Med J. Pietro Gentile et al. Stem Cells Trans Med 2015;4:
2 Recent media and internet attention Study of 71 men reporting persistent sexual side effects, lasting > than 3 mo after stopping finasteride 1 Recruited from website for men experiencing sexual dysfunction Retrospective data on sexual dysfunction or depression Followed these men for 2 more publications 3 rd study evaluated depression and found 75% of 61 patients reports depressive symptoms compared to controls with MPHL on college campus 2 Package insert: added persistent erectile dysfunction 2011 and libido/orgasm disorders 2012 Singh MK and Avram M meta-analysis 1 Prostate trials: more than 17,000 men in one trial looking at sexual dysfunction 2 and >1,300 in other trials with no persistent sexual side effects or depression MPHL trials: more than 2,500 with no persistent sexual dysfunction Belknap SM et al: questioning adequacy of safety reporting 3 Recommendations to patients: discuss outlier data on persistent sexual dysfunction with patients discuss safety seen in large trials discuss pre-existent sexual dysfunction and depression and treat only appropriate patients 1. Irwig MS, Kolakula S. J Sex Med Irwig MS. J Clin Pyschiat MK and Avram M. J of Clin Aesthet Dermatol, Monpour CM et al. J Natl Ca Inst Belknap et al. JAMA Derm, 2015 Corticosteroids Topical Intralesional Systemic Topical Immunotherapy Minoxidil 5% Anthralin Excimer Laser Other immunosuppressive agents (ie MTX, JAK inhibitors) Cytotoxic NKD2+ T cells are necessary and sufficient to induce alopecia in mice Interleukin 15 (required for the growth of natural killer cells) has been identified as a potential therapeutic target Janus kinase (JAK) inhibitors can affect signaling pathway of IL 15 1 Inhibition of JAK-STAT signaling promotes hair growth by stimulating the activation and/or proliferation of HF stem cells 2 1. Xing L et al. Nature Med 2014;20: Harel S, et al. Sci Adv Oct; 1(9) 2
3 King B, Ko J et al poster, WCHR 2015, Miami, FL 47% improved by at least 25% in SALT score Low side effects, ophiasis improved more than totalis/universalis, shorter duration of hair loss better Recommendations to patients: Prescribe these drugs with caution New clinical trials with topical JAK inhibitors are underway Expense and short remissions may outweigh benefits 24 weeks of simvastatin/ezetimibe 40mg/10 mg in 19 patients with 40-70% scalp hair loss 14/19 responders Association of stable remission and on medication significant (p = 0.04) Patchy alopecia areata Topical clobetasol foam BID for 5 day per week Can use clobestasol cream under occlusion 5 nights per week Minoxidil 5% solution or foam daily Intralesional steroids (5-7.5 mg/cc up to 3 cc) every 6-8 weeks Totalis/Universalis Topicals as above Prednisone taper, Methotrexate, Excimer laser, Immunotherapy Lattouf et al. JAAD Variant of lichenplanopilaris INCIDENCE APPEARS TO BE EXPLODING! Exam reveals progressive recession of fronto-temporal hair line with loss of follicular openings Atrophy of frontal scalp/forehead with vessel prominence Perifollicular erythema and hyperkeratosis in active areas Eyebrow loss Facial papules 3
4 TRACTION ALOPECIA Not complete loss Fringe sign FRONTAL FIBROSING ALOPECIA No fringe sign Psuedo-fringe Eyebrow loss Lonely hair Therapeutic ladder: Intralesional corticosteroids every 4-8 weeks Potent and ultrapotent topical steroids Hydroxychloroquine + quinacrine Methotrexate Mycophenylate mofitil P-PAR gamma agonist (pioglitazone, Actos )* 5 alpha reductase inhibitor Oral corticosteroid for severe, progressive disease Cyclosporine *Mirimani P, Karnik P. Arch Derm 2009 Dec;145(12) PPAR gamma important for healthy pilosebaceous units and loss of this function may trigger pathogenesis of LPP -Karnik P et al. J Invest Dermatol May;129(5): Studies N # Remission Sx Improvement s Baibergenova A, Walsh S. J Cutan Med Surg, 2012 Spring et al. JAAD, 2013 Mesinkovska NA et al. JAAD, 2015 Cessation due to side effects patients (343 women, 12 men) Eyebrow loss as initial presenting symptom was associated with milder disease Dutasteride or finasteride used in 111 (31%) patients with improvement in 52(47%) and stabilization in 59(53%) Recommendations to patients: Low side effect profile 50/50 chance of improvement/stabilization Recommendations to patients: 2 nd or 3 rd line drug Few remissions, limited likelihood of improvement High likelihood of side effects 4
5 Therapeutic ladder: Intralesional corticosteroids every 4-8 weeks * Potent and ultrapotent topical steroids * Hydroxychloroquine * +quinacrine Methotrexate * Mycophenylate mofitil * P-PAR gamma agonist (pioglitazone, Actos ) 5 alpha reductase inhibitor * Oral corticosteroid for severe, progressive disease Cyclosporine 105 articles on hair loss and African Americans in Pub Med from articles on dissecting cellulitis 65 articles on Central Centrifugal Cicatricial Alopecia 101 articles on Pseudofolliculitis barbae >40,000 articles on psoriasis > 20,000 articles on atopic dermatitis TOP DIAGNOSES IN AFRICAN AMERICAN PATIENT VISITS TO DERMATOLOGISTS NATIONAL AMBULATORY MEDICAL CARE SURVEY Diagnosis ICD-9 Code No. of Visits % of Visits Acne ,720, % Unspec. dermatitis ,640, % TOP DIAGNOSES IN AFRICAN AMERICAN PATIENT VISITS TO DERMATOLOGISTS NATIONAL AMBULATORY MEDICAL CARE SURVEY Diagnosis ICD-9 Code No. of Visits % of Visits Acne ,720, % Unspec. dermatitis ,640, % Seb dermatitis ,990, % Seb dermatitis ,990, % Atopic derm ,590, % Dyschromia ,290, % Psoriasis , % Alopecia , % Keloid scar , % Viral warts , % Sebaceous cyst , % Atopic derm ,590, % Dyschromia ,290, % Psoriasis , % Alopecia , % Keloid scar , % Viral warts , % Sebaceous cyst , % Davis SA, et al. J Drugs Dermatol 2012 Davis SA, et al. J Drugs Dermatol 2012 CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA CENTRAL CENTRIFUGAL SCARRING ALOPECIA EPIDEMIOLOGY Prevalence ranges from 2.7% in 604 South African women to 5.6% in 529 US women 1,2 Wide range of clinical severity Symptoms range from none to severe pruritus and pain Mostly women of African descent, ages Often accompanied by traction alopecia Pre-dated chemical relaxers Traction common theme 1. Khumalo NP et al, BJD Olsen EA et al, JAAD Yolanda Lenzy, personal communication, AAD
6 Central Scalp Alopecia Photographic Scale in African American Women Olsen EA, Callender V, Sperling L, McMichael A, Anstrom KJ, Bergfeld W, Durden F, Roberts J, Shapiro J and Whiting DA Derm Therapy Vol 21, 2008 CENTRAL HAIR LOSS IN AFRICAN AMERICAN WOMEN: INCIDENCE AND POTENTIAL RISK FACTORS JAAD 2011;64(2): ELISE A OLSEN, MD, VALERIE CALLENDER, MD, AMY MCMICHAEL, MD, LEONARD SPERLING, MD, KEVIN J. ANSTROM, PHD, JERRY SHAPIRO, MD, JANET ROBERTS, MD, FAITH DURDEN, MD, DAVID WHITING, MD AND WILMA BERGFELD, MD Incidence and patterns of central hair loss and the relationship of hair care practices, family history of hair loss and underlying medical conditions Extensive central scalp hair loss was seen in 5.6% in 529 subjects at 4 sites No association of extensive hair loss with relaxer, hot comb use, prior history of seborrheic dermatitis, reaction to a hair care product, bacterial infection, male pattern hair loss in fathers of subjects, however there was an association with a history of tinea capitis. Supported by the NAHRS and an unrestricted educational grant from Procter and Gamble Inflammation Hormonal? Inflammation Inflammation 6
7 TRACTION ALOPECIA Not complete loss Fringe sign FRONTAL FIBROSING ALOPECIA No fringe sign Psuedo-fringe Eyebrow loss Lonely hair Epidemiology not known Can occur alone or with other forms of hair loss Often requires biopsy to diagnose Retrospective study of patients staged at beginning and end of treatment Treatment = IL Kenalog, topical steroids, +/- minoxidil N = 15 After treatment: 5/15 (33.3%) had decreased severity scores (Improved) 8/15 (53.3%) had increased severity scores (Worsened) 2/15 (13.3%) had no change in severity scores FPHL FPHL with CCCA TREATMENT OF CCCA Biopsy for extent of inflammation/alternate diagnosis Inflammatory Stage Decrease heat to vertex Decrease all traumatic hair styling methods Decrease inflammation via topical and intralesional corticosteroids IL for 8 rounds with mg/cc for max 3 cc/visit (q 6-8 weeks) Oral/topical antibiotics for pustular disease Push treatment until symptom free Post-inflammatory treatment Monixidil solution for prolongation of anagen Surgical restoration 7
8 NIGERIAN WOMAN TREATMENT : IL KENALOG AND HAIR RESTORATION Pretreatment Post-treatment Dlova et al, Autosomal dominant inheritance of central centrifugal cicatricial alopecia in black South Africans. JAAD, 2014;70: index families with 31 immediate family members Pedigree analysis suggests autosomal dominance EXCITING RESEARCH 47% of nearly 6,000 African American women participants had crown hair loss in the Black Women s Health Study at Boston University 1 THANK YOU FOR YOUR ATTENTION! 1. Yolanda Lenzy, personal communication, AAD
6/30/2015. Many patients with more than one form of alopecia, but they think of it as one entity. and Gamble, Galderma, Sanumed
Amy McMichael, MD Professor and Chair Department of Dermatology Wake Wk Forest Baptist i Medical l Center Winston Salem, NC Pacific Dermatology Meeting 2015 Investigator: Consultant: Allergan, Intendis/Bayer,
More informationDiagnosis and Management of the Hair Loss Patient: Pearls and Pitfalls
Diagnosis and Management of the Hair Loss Patient: Pearls and Pitfalls U033 July 30 th 2017 7:30-8:30AM Paradi Mirmirani, MD The Permanente Medical Group, Vallejo, CA Regional Director, Hair Disorders
More informationUpdate on African American Hair and Scalp Disorders
Update on African American Hair and Scalp Disorders Heather Woolery-Lloyd, M.D. Director of Ethnic Skin Care Voluntary Assistant Professor Miller/University of Miami School of Medicine Department of Dermatology
More informationTips on Evaluation and Diagnosis of Scarring Alopecias. Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic
Tips on Evaluation and Diagnosis of Scarring Alopecias Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic Disclosures I do not have any relevant relationships with industry Investigator:
More informationJERRY SHAPIRO, MD, FAAD PROFESSOR
The Ronald O. Perelman Department of Dermatology Novel treatments for hair regrowth Where are we? JERRY SHAPIRO, MD, FAAD PROFESSOR AAD Chicago 2018 Disclosures Consultant/Investigator for: Aclaris Samumed
More informationLichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience
Original article CED Clinical and Experimental Dermatology Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience F. Mardones 1 and J. Shapiro
More informationNew Patient Hair Loss: Now What? Melissa Piliang, MD Cleveland Clinic Dermatology and Pathology
New Patient Hair Loss: Now What? Melissa Piliang, MD Cleveland Clinic Dermatology and Pathology Conflict of Interest No relevant conflicts Investigator for Samumed, Kythera, Incyte, Concert, Allergan Advisory
More informationSnapshot Dx Quiz: September 2018 Detailed Answers
Snapshot Dx Quiz: September 2018 Detailed Answers Cynthia X. Wang, BA 1 Milan J. Anadkat, MD 1,2 1 Washington University School of Medicine, St. Louis, Missouri 2 Division of Dermatology, St. Louis, Missouri
More informationDutasteride female pattern hair loss management 49, 50 male baldness management 41, 42 Dyeing, see Hair care
Subject Index Acne keloidalis nuchae, ethnic patients 146, 147 Actinic keratosis, ultraviolet radiation exposure 108 Aging hair effects 4, 5 melanocyte aging 130 132 molecular mechanisms 5 7 pigment loss,
More informationHOW TO BEST MANAGE ALOPECIA IN Kristen Fernandez, MD Department of Dermatology University of Missouri Harry S Truman VA
HOW TO BEST MANAGE ALOPECIA IN 2018 Kristen Fernandez, MD Department of Dermatology University of Missouri Harry S Truman VA MOST COMMON TYPES OF ALOPECIA Non scarring Androgenetic alopecia Alopecia areata
More informationWhat s New in Alopecia Areata
AN UPDATE ON THE LAST 12 MONTHS What s New in Alopecia Areata PhD FRCPC Dermatologist Assistant Professor, University of Toronto Getting information out to Physicians Five new studies to discuss Can cholesterol
More informationAntonella Tosti Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery
Dermoscopy in the evaluation and treatment of hair loss Antonella Tosti Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Antonella Tosti, MD
More informationLichen planopilaris and its variants. Antonella Tosti. Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery
Lichen planopilaris and its variants Antonella Tosti Fredric Brandt Endowed Professor of Dermatology & Cutaneous Surgery DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Antonella Tosti, MD S023 Lichen planopilaris
More informationFAST FACTS FOR BOARD REVIEW
FAST FACTS FOR BOARD REVIEW Series Editor: William W. Huang, MD, MPH Common Hair Disorders Rita Pichardo-Geisinger, MD Dr. Pichardo-Geisinger is Associate Professor of Dermatology, Wake Forest Baptist
More informationWhat Are the Different Forms?
SCARRING/CICATRICIAL ALOPECIA Scarring alopecia also known as cicatricial alopecia, refers to a collection of hair loss disorders that may be diagnosed in up to 3% of hair loss patients. It occurs worldwide
More informationTips on getting the most from your alopecia pathology reports. D irector, H a ir C linic, Boston Medical C e n ter
Tips on getting the most from your alopecia pathology reports Lynne J. Goldberg, MD J a g Bhawan Professor o f Dermatology a n d Pathology & Laboratory Medicine Boston U n iversity School of Medicine D
More informationIs Platelet Rich Plasma Injection an Effective Treatment for Hair Loss in Androgenic Alopecia and Alopecia Areata?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 11-2016 Is Platelet Rich Plasma Injection
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationCentral centrifugal cicatricial alopecia an approach to diagnosis and management
Review Central centrifugal cicatricial alopecia an approach to diagnosis and management Pamela Summers, MD, MBA, Angela Kyei, MD, MPH, and Wilma Bergfeld, MD Cleveland Clinic, Department of Dermatology,
More informationJAK Inhibitor CTP-543 Achieves Primary Endpoint in Phase 2 Trial in Alopecia Areata An interim analysis of 4 and 8 mg BID
American Academy of Dermatology Annual Meeting March 2, 2019 JAK Inhibitor CTP-543 Achieves Primary Endpoint in Phase 2 Trial in Alopecia Areata An interim analysis of 4 and 8 mg BID James Cassella, PhD;
More informationAlopecia areata: Workup and treatment
Alopecia areata: Workup and treatment Carolyn Goh Assistant Clinical Professor David Geffen School of Medicine at UCLA Department of Medicine-Dermatology February 2018 DISCLOSURE OF RELATIONSHIPS WITH
More informationDermatopathology Workshop Summary, Berlin 2004
Dermatopathology Workshop Summary, Berlin 2004 David A. Whiting and Rolf Hoffmannw Baylor Hair Research and Treatment Center, Dallas, Texas, USA; wdermatology Practice, Freiburg, Germany Figure 1 Case
More informationKEY ISSUES IN SKIN OF COLOR
KEY ISSUES IN SKIN OF COLOR Amy McMichael, MD Professor and Chair Department of Dermatology Wake Forest Baptist Medical Center Winston-Salem, NC Real World for Residents 2017 SC Derm 2019 1 DISCLOSURE/CONFLICTS
More informationINTRALESIONAL PLATELET RICH PLASMA vs INTRALESIONAL TRIAMCINOLONE IN THE TREATMENT OF ALOPECIA AREATA: A COMPARATIVE STUDY
International Journal of Medical Research & Health Sciences www.ijmrhs.com Volume 4 Issue 1 Coden: IJMRHS Copyright @214 ISSN: 2319-5886 Received: 3 rd Oct 214 Revised: 7 th Dec 214 Accepted: 17 th Dec
More informationDisclosure Statement:
Hair Loss Disorders Daniel Stulberg, MD Professor of Family and Community Medicine University of New Mexico Some slides courtesy E.J. Mayeaux, Jr., MD 1 Disclosure Statement: Co-Author, Dermatologic and
More informationNkanyezi Ferguson, MD, FAAD University of Iowa Hospital and Clinics Iowa City, IA
Nkanyezi Ferguson, MD, FAAD University of Iowa Hospital and Clinics Iowa City, IA U030 - Hair Care Practices and Hair Disorders in Skin of Color DISCLOSURES No relevant relationships with industry To discuss
More informationFrontal fibrosing alopecia severity index (FFASI): a validated scoring system for assessing frontal fibrosing alopecia
Received Date : 22-Jul-2015 Accepted Article Revised Date : 10-Jan-2016 Accepted Date : 11-Jan-2016 Article type : Research Letter Frontal fibrosing alopecia severity index (FFASI): a validated scoring
More informationALOPECIA AREATA RESEARCH SUMMIT Forging the Future
ALOPECIA AREATA RESEARCH SUMMIT Forging the Future PRELIMINARY PROGRAM Tuesday, December 4 Wednesday, December 5, 2018 Lerner Hall, Columbia University, New York City, USA Summit Co-Chairs Jerry Shapiro,
More informationHair Disorders A Case Based Approach
Hair Disorders A Case Based Approach Daniel Stulberg, MD Professor of Family and Community Medicine University of New Mexico Some slides courtesy E.J. Mayeaux, Jr., MD 1 Disclosure Statement: Co-Author,
More informationDISCLOSURES WHAT S NEW AND EXCITING FROM JAAD
WHAT S NEW AND EXCITING FROM JAAD Bruce H. Thiers, MD, Editor, JAAD Professor, Medical University of South Carolina Department of Dermatology and Dermatologic Surgery DISCLOSURES PFIZER VALEANT EFFECT
More informationPearls and Pitfalls in the treatment of hair loss in women
The Ronald O. Perelman Department of Dermatology Pearls and Pitfalls in the treatment of hair loss in women JERRY SHAPIRO, MD, FAAD PROFESSOR Chicago Summer AAD Disclosures Consultant/Investigator for:
More informationCHAPTER 22 Brocq s alopecia (pseudopelade of Brocq) and burnt out scarring alopecia
CHAPTER 22 Brocq s alopecia (pseudopelade of Brocq) and burnt out scarring alopecia BROCQ S ALOPECIA The term pseudopelade of Brocq is a source of much confusion and fruitless debate, and should be abandoned.
More informationDiscoid Lupus Erythematosus
S023 Hair and Scalp Dermoscopy Discoid Lupus Erythematosus Bruna Duque Estrada, M.D. Instituto de Dermatologia Prof. Rubem David Azulay Rio de Janeiro, Brazil. Disclosure of Relationship with Industry
More informationTable of Contents: Part 1 Medical Dermatology. Chapter 1 Acneiform Disorders. Acne. Acne Vulgaris. Pomade Acne. Steroid Acne
Table of Contents: Part 1 Medical Dermatology Chapter 1 Acneiform Disorders Acne Acne Vulgaris Pomade Acne Steroid Acne Infantile Acne Pediatric Perspectives Neonatal Acne (Acne Neonatorum) Pediatric Perspectives
More informationHair Research in 2017: A Look Back at 20 Research Papers that Influenced My Practice. Jeff Donovan MD PhD, Dermatologist Vancouver, Canada
Hair Research in 2017: A Look Back at 20 Research Papers that Influenced My Practice Jeff Donovan MD PhD, Dermatologist Vancouver, Canada As 2018 unravels, I find it important to reflect on the year that
More informationWhat's New in Oncodermatopathology: Immunotherapy Reactions
What's New in Oncodermatopathology: Immunotherapy Reactions Emily Y. Chu, M.D., Ph.D. Assistant Professor of Dermatology & Pathology and Laboratory Medicine Hospital of the University of Pennsylvania March
More informationORIGINAL INVESTIGATION. Most Common Dermatologic Problems Identified by Internists,
ORIGINAL INVESTIGATION Most Common Dermatologic Problems Identified by Internists, 1990-1994 Steven R. Feldman, MD, PhD; Alan B. Fleischer, Jr, MD; R. Carol McConnell, BS Background: Internists in all
More informationALOPECIA AREATA RESEARCH SUMMIT Forging the Future
ALOPECIA AREATA RESEARCH SUMMIT Forging the Future PRELIMINARY PROGRAM Tuesday, December 4 Wednesday, December 5, 2018 Lerner Hall, Columbia University, New York City, USA Summit Co-Chairs Jerry Shapiro,
More informationIt is not invisible! A case report of 2 patients with scalp Lichen Planopilaris mimicking Androgenic Alopecia
Open Access Annals of Dermatological Research Case Report It is not invisible! A case report of 2 patients with scalp Lichen Planopilaris mimicking Androgenic Alopecia Sorbellini Elisabetta 1, Pinto Daniela
More informationCHERRY CREEK RESEARCH INC. CLINICAL RESEARCH COMPLETED PRINCIPAL INVESTIGATOR- J. MICHAEL MALONEY III, MD
CLINICAL STUDY CHERRY CREEK RESEARCH INC. CLINICAL RESEARCH COMPLETED PRINCIPAL INVESTIGATOR- J. MICHAEL MALONEY III, MD SUB-P.I. STUDY Rosacea, Topical, 2011-2012, (Galderma), Multicenter, Open- Label
More informationACNE BOOT CAMP TOPICAL THERAPY BASICS
ACNE BOOT CAMP TOPICAL THERAPY BASICS Lawrence J Green, MD Associate Clinical Professor of Dermatology George Washington University School of Medicine Washington DC Relevant Disclosures Investigator -Allergan,
More informationDermoscopic Approach to a Small Round to Oval Hairless Patch on the Scalp
Ann Dermatol Vol. 26, No. 2, 2014 http://dx.doi.org/10.5021/ad.2014.26.2.214 ORIGINAL ARTICLE Dermoscopic Approach to a Small Round to Oval Hairless Patch on the Scalp Woo-Haing Shim 1, Seung-Wook Jwa
More informationFIBROSING ALOPECIA IN A PATTERN DISTRIBUTION IN TWO BROTHERS WITH PILI MULTIGEMINI
FIBROSING ALOPECIA IN A PATTERN DISTRIBUTION IN TWO BROTHERS WITH PILI MULTIGEMINI B D S B S M Department of Dermatology and Venereology, ed al a lty, ed al n er ty o a Summary. presence of several hairs
More informationStrathprints Institutional Repository
Strathprints Institutional Repository Holmes, S. and Ryan, T. and Young, D. and Harries, M. (2016) Frontal fibrosing alopecia severity index (FFASI) : a validated scoring system for assessing frontal fibrosing
More informationTeledermatology. Acne. What the primary care physician needs to know in the world of increased access
Teledermatology What the primary care physician needs to know in the world of increased access Toby Maurer, MD University of California, San Francisco In the world of dermatology-teledermatology is powering
More informationRashes Not To Be Missed In Children
May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if
More informationUpdate on systemic therapies and emerging treatments How do I choose a systemic agent?
Update on systemic therapies and emerging treatments How do I choose a systemic agent? Amy S. Paller, M.D. Walter J. Hamlin Professor and Chair of Dermatology Professor of Pediatrics Northwestern University
More informationDermatology GP Referral Guidelines
Austin Health Dermatology Department holds 5 Clinic sessions to discuss and plan the treatment of with Dermatology conditions. Department of Health clinical urgency categories for specialist clinics Urgent:
More informationStaying A- Head in Pediatric Dermatology:
Staying A- Head in Pediatric Dermatology: Common Scalp and Hair Diagnoses Matt Grisham, MD Greenville Health System Post-Graduate Seminar April 20, 2016 I have no financial disclosures or conflicts of
More informationBrazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
Rheumatol Ther (2017) 4:503 508 DOI 10.1007/s40744-017-0069-z CASE SERIES Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series Morton
More informationPhototherapy for Psoriasis. Henry W. Lim, MD Chairman and C.S. Livingood Chair Department of Dermatology Henry Ford Hospital, Detroit, MI, USA
Phototherapy for Psoriasis Henry W. Lim, MD Chairman and C.S. Livingood Chair Department of Dermatology Henry Ford Hospital, Detroit, MI, USA Disclosure Investigator: Clinuvel Estée Lauder Ferndale Incyte
More informationTreatment of alopecia universalis with topical Janus kinase inhibitors a double blind, placebo, and active controlled pilot study
Report Treatment of alopecia universalis with topical Janus kinase inhibitors a double blind, placebo, and active controlled pilot study Laita Bokhari, MPhil Med, and Rodney Sinclair, MBBS, MD, FACD Sinclair
More informationMAY 5-6, Crowne Plaza Times Square NEW YORK, NY
MAY 5-6, 2018 Crowne Plaza Times Square NEW YORK, NY MAY 5-6, 2018 CROWNE PLAZA TIMES SQUARE NEW YORK, NY THE 10 TH SEMINAR IN THE SERIES Dermatology for Today s Global Community The 10th Skin of Color
More informationEfficacy of Topical Diphencyprone in the Treatment of Alopecia Areata
Original Article Efficacy of Topical Diphencyprone in the Treatment of Alopecia Areata Maryam Akhiani, MD Hasan Seyrafi, MD Farshad Farnaghi, MD Parastoo Banan, MD Vahideh Lajvardi, MD Department of Dermatology,
More informationJerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada. Pathogenesis & management of acne scarring
Jerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada Pathogenesis & management of acne scarring Disclosures Relationships with commercial interests: Abbott Laboratories A(Grants/Research
More informationCompany Overview. Dr. Neal Walker President and CEO. September Copyright 2016 Aclaris Therapeutics. All rights reserved.
Company Overview Dr. Neal Walker President and CEO Copyright 2016 Aclaris Therapeutics. All rights reserved. A-11 Disclaimer This presentation contains forward-looking statements, including statements
More informationAuthors: Raja ni N a lluri A a nd M at t hew H a r rie s B. Hair follicles, the hair cycle and hair loss ABSTRACT. Introduction
CME DERMATOLOGY Clinical Medicine 2016 Vol 16, No 1: 74 8 Alopecia in general medicine Authors: Raja ni N a lluri A a nd M at t hew H a r rie s B ABSTRACT Appreciation of different types of hair loss (alopecia)
More informationHair loss is stressful and cosmetically concerning
Review An Approach to Shannon Harrison, MBBS; Melissa Piliang, MD; Wilma F. Bergfeld, MD Hair loss is a common symptom presenting in women, and there are a range of conditions that can cause hair loss
More informationClinical Policy Title: Alopecia areata
Clinical Policy Title: Alopecia areata Clinical Policy Number: 16.02.03 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: September 21, 2017 Next Review Date:
More informationA Novel Approach for Acne Treatment
A Novel Approach for Acne Treatment E.V. Ross, M.D.; M.A. Blair, M.D.; B.S. Graham, M.D.; Naval Medical Center, San Diego, CA D.Y. Paithankar, Ph.D.; B.A. Saleh, M.Eng.; Candela Corporation, Wayland, MA
More informationEvaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia
doi:./j.46-88.2.78.x Journal of Dermatology 22; 9: 27 2 ORIGINAL ARTICLE Evaluation of efficacy and safety of finasteride mg in 77 Japanese men with androgenetic alopecia Akio SATO, Akira TAKEDA 2 Tokyo
More informationTHINKING OUTSIDE THE BOX Ted Rosen, MD Baylor College of Medicine Houston, Texas
THINKING OUTSIDE THE BOX Ted Rosen, MD Baylor College of Medicine Houston, Texas RADICAL TOPICAL THERAPEUTIC PEARLS {SOMETIMES BASED ON BASICS} Hong Kong Jade Market 2014 ZINC! DISCLOSURE OF RELATIONSHIPS
More informationHow to decipher a pathology report for alopecia
How to decipher a pathology report for alopecia DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Lynne J. Goldberg, MD S063-Hair Disorders Made Easier DISCLOSURES I do not have any relationships with industry
More informationAn Update on Topical Therapy for Atopic Dermatitis
An Update on Topical Therapy for Atopic Dermatitis Amy S. Paller, M.D. Professor and Chair of Dermatology Professor of Pediatrics Northwestern University Feinberg School of Medicine Chicago, Illinois Disclosures
More informationClinical Policy Title: Alopecia areata
Clinical Policy Title: Alopecia areata Clinical Policy Number: CCP.1134 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: August 1, 2018 Next Review Date:
More informationchemotherapeutic agents in
Use of biologics and chemotherapeutic agents in cutaneous emergencies: Focus on lifethreatening forms of psoriasis Alice Bendix Gottlieb MD, PhD Professor of Dermatology New York Medical College Metropolitan
More informationSkin Side Effects U N I V E R S I T Y OF V I E N N A, D E P A R T M E N T OF O N C O L O G Y, G E N E R A L H O S P I T A L V I E N N A
Skin Side Effects Christiane Thallinger, M D U N I V E R S I T Y OF V I E N N A, D E P A R T M E N T OF O N C O L O G Y, G E N E R A L H O S P I T A L V I E N N A Targets Substances 1 Multi Kinase Inhibitors
More informationGENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM
GENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM Telogen effluvium is a form of diffuse hair loss that occurs during the telogen or resting phase of the hair growth cycle. Telogen
More informationClinical Efficacy and Safety of Methotrexate versus Hydroxychloroquine in Preventing Lichen Planopilaris Progress: A Randomized Clinical Trial
Original Article Clinical Efficacy and Safety of Methotrexate versus Hydroxychloroquine in Preventing Lichen Planopilaris Progress: A Randomized Clinical Trial Abstract Background: Lichen planopilaris
More informationMegha M. Tollefson, MD Associate Professor of Dermatology and Pediatrics, Mayo Clinic Pediatric Morphea March 1, MFMER
Megha M. Tollefson, MD Associate Professor of Dermatology and Pediatrics, Mayo Clinic Pediatric Morphea March 1, 2019 2015 MFMER 3513105-1 Disclosures None 2015 MFMER 3513105-2 Topics to cover Classification
More informationDisclosure Statement: Life Cycle of a Hair. Objectives. Life Cycle of a Hair. Hair Classification. Hair Disorders A Case Based Approach
Hair Disorders A Case Based Approach Daniel Stulberg, M.D. Prof. of Family and Community Medicine University of New Mexico Some slides courtesy EJ Mayeaux, M.D. Disclosure Statement: Co-Author, Dermatologic
More informationEconomic Evaluation of Apremilast in the Treatment of Moderate to Severe Psoriasis in the United States
1142 Economic Evaluation of Apremilast in the Treatment of Moderate to Severe Psoriasis in the United States Tom Tencer, PhD 1 ; Zoe Clancy, PharmD, MS 1 ; Vidya Damera, MS 2 ; Frank Zhang MD, MPH 1 ;
More informationAlopecia. Antonella Tosti. Fredric Brandt Endowed Professor of Dermatology&Cutaneous Surgery Miller School of Medicine, University of Miami
Alopecia Antonella Tosti Fredric Brandt Endowed Professor of Dermatology&Cutaneous Surgery Miller School of Medicine, University of Miami DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Antonella Tosti, MD S049
More informationDermatopathology Case Challenge: Recognizing Mimics and Masqueraders
Dermatopathology Case Challenge: Recognizing Mimics and Masqueraders Rosalie Elenitsas, M.D. Professor of Dermatology Director, Dermatopathology University of Pennsylvania DISCLOSURE OF RELATIONSHIPS WITH
More informationPoonkiat Suchonwanit, MD Hair and Scalp Disorders Unit Division of Dermatology Department of Medicine Ramathibodi Hospital
Poonkiat Suchonwanit, MD Hair and Scalp Disorders Unit Division of Dermatology Department of Medicine Ramathibodi Hospital Hair loss Excessive hair growth Hair haft abnormalities Hair color Anagen Catagen
More informationPsoriasiform Dermatitis in Children: Calling in the Troops
Psoriasiform Dermatitis in Children: Calling in the Troops Markus Boos, MD PhD Attending Physician, Dermatology Seattle Children s Hospital Assistant Professor of Pediatrics, University of Washington School
More informationOptimizing Topical Therapy In Atopic Dermatitis
Optimizing Topical Therapy In Atopic Dermatitis Steven R. Feldman, MD, PhD Professor of Dermatology, Pathology & Public Health Sciences Wake Forest University School of Medicine Winston-Salem, North Carolina,
More informationDouglas N. Robins, M.D. Ameriderm Research
Curriculum Vitae Douglas N. Robins, M.D. Ameriderm Research Office Address: Leavitt Medical Associates of Florida (DBA) Advanced Dermatology and Cosmetic Surgery Ameriderm Research 4100 Southpoint Dr.
More informationMUCOCUTANEOUS MANIFESTATIONS OF HIV/AIDS IN ADOLESCENTS
MUCOCUTANEOUS MANIFESTATIONS OF HIV/AIDS IN ADOLESCENTS Dr. Y.S.MARFATIA Prof. and Head, Dept. Skin & V.D. Medical college, Vadodara LET US CREATE BRILLIANCE TOGETHER MEDICAL COLLEGE, VADODARA Editor in
More informationCOMPLEX CUTANEOUS LUPUS CASES PEARLS AND PITFALLS
COMPLEX CUTANEOUS LUPUS CASES PEARLS AND PITFALLS Benjamin F. Chong, MD, MSCS February 17, 2018 CONFLICTS OF INTEREST D I S CLOSURE OF R E LATI ONSHIPS W I T H I NDUSTRY Benjamin Chong, MD, MSCS F059 Complex
More informationFemale pattern hair loss
Female pattern hair loss Linda Chan, David K Cook Background Female pattern hair loss (FPHL) is a commonly encountered clinical presentation in primary care. Patterned hair loss in women is characterised
More informationPresented by: Adelaide A Hebert, MD UTHealth McGovern Medical School, Houston, TX
Evaluation of the Efficacy, Safety and Tolerability of 4% Once-Daily in Subjects with Moderate to Severe Acne Vulgaris Treated Topically for Up to 52 Weeks A Hebert, J Del Rosso, M Rico, R Woolson, E de
More informationTinea: Head to Toe A dermatophyte tour of human skin. Tour de Tinea Head to Toe. Tips for Tinea Head to Toe. Psoriasis. Non-inflammatory Tinea Capitis
Tinea: Head to Toe A dermatophyte tour of human skin Renee Howard, MD Assistant Clinical Professor of Dermatology, UCSF Tour de Tinea Head to Toe Tips for Tinea Head to Toe Capitis Faciei Corporis Pedis
More informationImpact of female pattern hair loss on the quality of life of patients
Original Article Impact of female pattern hair loss on the quality of life of patients P Shilpashree, Syrti Clarify, AK Jaiswal, T Shashidhar Department of Skin and STD, Dr. B. R. Ambedkar Medical College,
More informationA Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
Cyclosporine and Steroid Minipulse Therapy in AA pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 28, No. 5, 2016 http://dx.doi.org/10.5021/ad.2016.28.5.569 ORIGINAL ARTICLE A Comparative Study of Oral
More informationThe value of dermoscopy in diagnosing eyebrow loss in patients with alopecia areata and frontal fibrosing alopecia
DOI: 10.1111/jdv.15279 JEADV ORIGINAL ARTICLE The value of dermoscopy in diagnosing eyebrow loss in patients with alopecia areata and frontal fibrosing alopecia A. Waskiel-Burnat, 1 A. Rakowska, 1, * M.
More informationRecalcitrant Warty Erythroderma With Severe Pruritus. Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University
Recalcitrant Warty Erythroderma With Severe Pruritus Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University DISCLOSURE OF RELEVANT RELATIONSHIPS WITH INDUSTRY Gil Yosipovitch,
More informationRosacea Update: Rosacea pathogenesis. Rosacea genetics. Disclosures. Rosacea: Etiology? Th1/Th17 is activated in rosacea skin
Winter Clinical Big Island 20 min Rosacea Update: 2017 Diane M. Thiboutot, M.D. Professor of Dermatology The Pennsylvania State University College of Medicine Hershey, PA Disclosures Investigator or consultant
More informationCOMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio
COMMON SKIN CONDITIONS IN PRIMARY CARE Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio DISCLOSURE The Speaker and members of the planning committee do not have a conflict of interest
More informationSHORT REPORT FRONTAL FIBROSING ALOPECIA IN A PREMENOPAUSAL WOMAN: IMMUNOHISTOCHEMICAL AND IMMUNOFLUORESCENCE ANALYSIS
EUROPEAN JOURNAL OF INFLAMMATION Vol. 5, no. 1, 23-27 (2007) SHORT REPORT FRONTAL FIBROSING ALOPECIA IN A PREMENOPAUSAL WOMAN: IMMUNOHISTOCHEMICAL AND IMMUNOFLUORESCENCE ANALYSIS G.I. ATHANASIADIS, E.
More informationSubspecialty Rotation: Dermatology
Subspecialty Rotation: Dermatology Faculty: Wesley Galen, M.D. GOAL: Prevention, Counseling and Screening (Dermatology). Understand the pediatrician's role in preventing illness and dysfunction related
More informationDermclinic
Dermclinic /Dermclinic A Photo Quiz to Hone Dermatologic Skills DAVID L. KAPLAN, MD Series Editor University of Missouri Kansas City, University of Kansas Case 1: Upon his return from a summer visit to
More informationWorld Journal of Pharmaceutical Research
Shraddhamayananda SJIF Impact Factor 5.045 Volume 3, Issue 6, 618-625. Research Article ISSN 2277 7105 EFFICACY OF HOMEOPATHIC MEDICINES IN THE TREATMENT OF ACNE *Swami Shraddhamayananda Ramakrishna Mission
More informationIndex. B Bcl-2 expression, 111 Behavioral therapy, 65 Beta blockers, 20, 76 Biopsy, 10, 25, 57, 72
Index A ACE inhibitors, 76 Acetonide, 82 Acrodermatitis enteropathica, 20 Active phase, 89 Acute cutaneous LE (ACLE), 71 Albendazole/mebendazole, 20 Allergic rhinitis, 44 Allopurinol, 20 Alopecia categorization,
More informationCORE CURRICULUM IN HAIR RESTORATION SURGERY Revised July 22, 2009
1. BASIC SCIENCE... 4 1.1. BASIC SCIENCE OF HAIR... 4 1.1.1. Scalp Anatomy and Physiology... 4 1.1.2. Cyclic Activity of Hair... 4 1.1.3. Androgen-dependent Hair... 4 1.1.4. Pathophysiology of androgenic
More informationAndrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada
Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada Copyright 2017 by Sea Courses Inc. All rights reserved.
More informationPROCEEDINGS PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP
PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP A HEALTHY 4-WEEK-OLD INFANT WITH ACNE A 4-week-old infant was brought to the pediatrician s office by his parents following the appearance
More informationTreatment with steroids and immunosuppressants
Treatment with steroids and immunosuppressants Donna Culton, MD, PhD University of North Carolina IPPF 2017 Annual Patient Conference Newport Beach, CA September 16, 2017 Factors that will influence therapy
More informationA Vitiligo Update for Pharmacists: Current Practices and Future Advances
A Vitiligo Update for Pharmacists: Current Practices and Future Advances Dalal Hammoudi Halat, RPh, MSc, PhD Assistant Professor School of Pharmacy, Lebanese International University Disclosure Dalal Hammoudi
More information